A vs RLMD · P/E 29, rev $1.88B vs $692.3M cap
Agilent Technologies Inc (A) versus Relmada Therapeutics Inc (RLMD) — a side-by-side from cached financials, not a winner call.
Agilent Technologies Inc (A) is a diagnostics & research company listed on US.
Relmada Therapeutics Inc (RLMD) is a biotechnology company listed on NASDAQ.
Latest reported A revenue for 2026-07-31 was $1.88B. Net income was $362.0M. Revenue was up 2.3% from 2026-04-30 to 2026-07-31. A currently screens at market cap $33.70B and trailing P/E 29.2.
RLMD does not have a complete income-statement cache yet.
A currently screens at market cap $33.70B and trailing P/E 29.2. RLMD currently screens at market cap $692.3M.
Not investment advice. Open the A and RLMD stock pages for the full models.
Not investment advice.